Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis
This study has been completed.
Study NCT01561352   Information provided by Novo Nordisk

First Received on March 21, 2012.   Last Updated on May 22, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Haemostasis
Haemorrhagic Cystitis
Additional conditions recognized in this trial
Cystitis
More general conditions related to this trial
Urinary Bladder Diseases
Urologic Diseases
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services